Canary Capital Amends Staked Injective ETF Filing with SEC, Sparking INJ Price Rally Speculation
Key Highlights Canary Capital has amended its S-1 filing with the SEC for a staked Injective (INJ) exchange-traded fund, signaling progress toward a regulated crypto investment product. The updated prospectus details structural changes designed to offer investors direct exposure to the Injective token and its native staking yield within a regulated framework. INJ token price ...